id	sid	tid	token	lemma	pos
cord-322798-5r3kf9wa	1	1	key	key	NN
cord-322798-5r3kf9wa	1	2	:	:	:
cord-322798-5r3kf9wa	2	1	cord-322798	cord-322798	VB
cord-322798-5r3kf9wa	2	2	-	-	HYPH
cord-322798-5r3kf9wa	2	3	5r3kf9wa	5r3kf9wa	CD
cord-322798-5r3kf9wa	2	4	authors	author	NNS
cord-322798-5r3kf9wa	2	5	:	:	:
cord-322798-5r3kf9wa	2	6	Freeman	Freeman	NNP
cord-322798-5r3kf9wa	2	7	,	,	,
cord-322798-5r3kf9wa	2	8	Esther	Esther	NNP
cord-322798-5r3kf9wa	2	9	E.	E.	NNP
cord-322798-5r3kf9wa	2	10	;	;	:
cord-322798-5r3kf9wa	2	11	McMahon	McMahon	NNP
cord-322798-5r3kf9wa	2	12	,	,	,
cord-322798-5r3kf9wa	2	13	Devon	Devon	NNP
cord-322798-5r3kf9wa	2	14	E.	E.	NNP
cord-322798-5r3kf9wa	2	15	title	title	NN
cord-322798-5r3kf9wa	2	16	:	:	:
cord-322798-5r3kf9wa	3	1	Creating	create	VBG
cord-322798-5r3kf9wa	3	2	Dermatology	Dermatology	NNP
cord-322798-5r3kf9wa	3	3	Guidelines	Guidelines	NNPS
cord-322798-5r3kf9wa	3	4	for	for	IN
cord-322798-5r3kf9wa	3	5	Covid-19	covid-19	NN
cord-322798-5r3kf9wa	3	6	:	:	:
cord-322798-5r3kf9wa	4	1	The	the	DT
cord-322798-5r3kf9wa	4	2	Pitfalls	pitfall	NNS
cord-322798-5r3kf9wa	4	3	of	of	IN
cord-322798-5r3kf9wa	4	4	Applying	apply	VBG
cord-322798-5r3kf9wa	4	5	Evidence	evidence	NN
cord-322798-5r3kf9wa	4	6	Based	Based	NNP
cord-322798-5r3kf9wa	4	7	Medicine	Medicine	NNP
cord-322798-5r3kf9wa	4	8	to	to	IN
cord-322798-5r3kf9wa	4	9	an	an	DT
cord-322798-5r3kf9wa	4	10	Emerging	emerge	VBG
cord-322798-5r3kf9wa	4	11	Infectious	Infectious	NNP
cord-322798-5r3kf9wa	4	12	Disease	Disease	NNP
cord-322798-5r3kf9wa	4	13	date	date	NN
cord-322798-5r3kf9wa	4	14	:	:	:
cord-322798-5r3kf9wa	4	15	2020	2020	CD
cord-322798-5r3kf9wa	4	16	-	-	HYPH
cord-322798-5r3kf9wa	4	17	04	04	CD
cord-322798-5r3kf9wa	4	18	-	-	HYPH
cord-322798-5r3kf9wa	4	19	09	09	CD
cord-322798-5r3kf9wa	4	20	journal	journal	NN
cord-322798-5r3kf9wa	4	21	:	:	:
cord-322798-5r3kf9wa	4	22	J	J	NNP
cord-322798-5r3kf9wa	4	23	Am	Am	NNP
cord-322798-5r3kf9wa	4	24	Acad	Acad	NNP
cord-322798-5r3kf9wa	4	25	Dermatol	Dermatol	NNP
cord-322798-5r3kf9wa	4	26	DOI	doi	NN
cord-322798-5r3kf9wa	4	27	:	:	:
cord-322798-5r3kf9wa	4	28	10.1016/	10.1016/	CD
cord-322798-5r3kf9wa	5	1	j.jaad.2020.04.002	j.jaad.2020.04.002	NFP
cord-322798-5r3kf9wa	6	1	sha	sha	NNP
cord-322798-5r3kf9wa	6	2	:	:	:
cord-322798-5r3kf9wa	7	1	370c1745232d28ee7bbf3fa762a61efd24262afa	370c1745232d28ee7bbf3fa762a61efd24262afa	NNP
cord-322798-5r3kf9wa	7	2	doc_id	doc_id	CD
cord-322798-5r3kf9wa	7	3	:	:	:
cord-322798-5r3kf9wa	7	4	322798	322798	CD
cord-322798-5r3kf9wa	7	5	cord_uid	cord_uid	NNS
cord-322798-5r3kf9wa	7	6	:	:	:
cord-322798-5r3kf9wa	8	1	5r3kf9wa	5r3kf9wa	CD
cord-322798-5r3kf9wa	8	2	nan	nan	NNP
cord-322798-5r3kf9wa	9	1	To	to	IN
cord-322798-5r3kf9wa	9	2	the	the	DT
cord-322798-5r3kf9wa	9	3	Editor	Editor	NNP
cord-322798-5r3kf9wa	9	4	:	:	:
cord-322798-5r3kf9wa	9	5	We	-PRON-	PRP
cord-322798-5r3kf9wa	9	6	recently	recently	RB
cord-322798-5r3kf9wa	9	7	co	co	VBD
cord-322798-5r3kf9wa	9	8	-	-	VBD
cord-322798-5r3kf9wa	9	9	authored	author	VBD
cord-322798-5r3kf9wa	9	10	a	a	DT
cord-322798-5r3kf9wa	9	11	piece	piece	NN
cord-322798-5r3kf9wa	9	12	in	in	IN
cord-322798-5r3kf9wa	9	13	the	the	DT
cord-322798-5r3kf9wa	9	14	JAAD	JAAD	NNP
cord-322798-5r3kf9wa	9	15	about	about	IN
cord-322798-5r3kf9wa	9	16	modifications	modification	NNS
cord-322798-5r3kf9wa	9	17	the	the	DT
cord-322798-5r3kf9wa	9	18	American	American	NNP
cord-322798-5r3kf9wa	9	19	Academy	Academy	NNP
cord-322798-5r3kf9wa	9	20	of	of	IN
cord-322798-5r3kf9wa	9	21	Dermatology	Dermatology	NNP
cord-322798-5r3kf9wa	9	22	(	(	-LRB-
cord-322798-5r3kf9wa	9	23	AAD	AAD	NNP
cord-322798-5r3kf9wa	9	24	)	)	-RRB-
cord-322798-5r3kf9wa	9	25	implemented	implement	VBD
cord-322798-5r3kf9wa	9	26	to	to	TO
cord-322798-5r3kf9wa	9	27	enhance	enhance	VB
cord-322798-5r3kf9wa	9	28	the	the	DT
cord-322798-5r3kf9wa	9	29	rigor	rigor	NN
cord-322798-5r3kf9wa	9	30	of	of	IN
cord-322798-5r3kf9wa	9	31	evidence	evidence	NN
cord-322798-5r3kf9wa	9	32	-	-	HYPH
cord-322798-5r3kf9wa	9	33	based	base	VBN
cord-322798-5r3kf9wa	9	34	clinical	clinical	JJ
cord-322798-5r3kf9wa	9	35	practice	practice	NN
cord-322798-5r3kf9wa	9	36	guidelines	guideline	NNS
cord-322798-5r3kf9wa	9	37	.	.	.
cord-322798-5r3kf9wa	10	1	1	1	LS
cord-322798-5r3kf9wa	11	1	Although	although	IN
cord-322798-5r3kf9wa	11	2	we	-PRON-	PRP
cord-322798-5r3kf9wa	11	3	believe	believe	VBP
cord-322798-5r3kf9wa	11	4	this	this	DT
cord-322798-5r3kf9wa	11	5	change	change	NN
cord-322798-5r3kf9wa	11	6	will	will	MD
cord-322798-5r3kf9wa	11	7	serve	serve	VB
cord-322798-5r3kf9wa	11	8	the	the	DT
cord-322798-5r3kf9wa	11	9	AAD	AAD	NNP
cord-322798-5r3kf9wa	11	10	well	well	RB
cord-322798-5r3kf9wa	11	11	in	in	IN
cord-322798-5r3kf9wa	11	12	the	the	DT
cord-322798-5r3kf9wa	11	13	future	future	NN
cord-322798-5r3kf9wa	11	14	,	,	,
cord-322798-5r3kf9wa	11	15	we	-PRON-	PRP
cord-322798-5r3kf9wa	11	16	must	must	MD
cord-322798-5r3kf9wa	11	17	be	be	VB
cord-322798-5r3kf9wa	11	18	flexible	flexible	JJ
cord-322798-5r3kf9wa	11	19	about	about	IN
cord-322798-5r3kf9wa	11	20	guideline	guideline	NN
cord-322798-5r3kf9wa	11	21	generation	generation	NN
cord-322798-5r3kf9wa	11	22	during	during	IN
cord-322798-5r3kf9wa	11	23	the	the	DT
cord-322798-5r3kf9wa	11	24	coronavirus	coronavirus	NN
cord-322798-5r3kf9wa	11	25	disease-2019	disease-2019	NNP
cord-322798-5r3kf9wa	11	26	(	(	-LRB-
cord-322798-5r3kf9wa	11	27	Covid-19	Covid-19	NNP
cord-322798-5r3kf9wa	11	28	)	)	-RRB-
cord-322798-5r3kf9wa	11	29	outbreak	outbreak	NN
cord-322798-5r3kf9wa	11	30	.	.	.
cord-322798-5r3kf9wa	12	1	Like	like	IN
cord-322798-5r3kf9wa	12	2	the	the	DT
cord-322798-5r3kf9wa	12	3	WHO	WHO	NNP
cord-322798-5r3kf9wa	12	4	,	,	,
cord-322798-5r3kf9wa	12	5	the	the	DT
cord-322798-5r3kf9wa	12	6	AAD	AAD	NNP
cord-322798-5r3kf9wa	12	7	already	already	RB
cord-322798-5r3kf9wa	12	8	adopted	adopt	VBD
cord-322798-5r3kf9wa	12	9	a	a	DT
cord-322798-5r3kf9wa	12	10	rapid	rapid	JJ
cord-322798-5r3kf9wa	12	11	advice	advice	NN
cord-322798-5r3kf9wa	12	12	guidelines	guideline	NNS
cord-322798-5r3kf9wa	12	13	protocol	protocol	NN
cord-322798-5r3kf9wa	12	14	,	,	,
cord-322798-5r3kf9wa	12	15	but	but	CC
cord-322798-5r3kf9wa	12	16	this	this	DT
cord-322798-5r3kf9wa	12	17	process	process	NN
cord-322798-5r3kf9wa	12	18	relies	rely	VBZ
cord-322798-5r3kf9wa	12	19	on	on	IN
cord-322798-5r3kf9wa	12	20	evaluating	evaluate	VBG
cord-322798-5r3kf9wa	12	21	a	a	DT
cord-322798-5r3kf9wa	12	22	body	body	NN
cord-322798-5r3kf9wa	12	23	of	of	IN
cord-322798-5r3kf9wa	12	24	evidence	evidence	NN
cord-322798-5r3kf9wa	12	25	,	,	,
cord-322798-5r3kf9wa	12	26	which	which	WDT
cord-322798-5r3kf9wa	12	27	does	do	VBZ
cord-322798-5r3kf9wa	12	28	not	not	RB
cord-322798-5r3kf9wa	12	29	yet	yet	RB
cord-322798-5r3kf9wa	12	30	exist	exist	VB
cord-322798-5r3kf9wa	12	31	for	for	IN
cord-322798-5r3kf9wa	12	32	Covid-19	covid-19	NN
cord-322798-5r3kf9wa	12	33	.	.	.
cord-322798-5r3kf9wa	13	1	To	to	TO
cord-322798-5r3kf9wa	13	2	address	address	VB
cord-322798-5r3kf9wa	13	3	this	this	DT
cord-322798-5r3kf9wa	13	4	gap	gap	NN
cord-322798-5r3kf9wa	13	5	,	,	,
cord-322798-5r3kf9wa	13	6	the	the	DT
cord-322798-5r3kf9wa	13	7	AAD	AAD	NNP
cord-322798-5r3kf9wa	13	8	established	establish	VBD
cord-322798-5r3kf9wa	13	9	the	the	DT
cord-322798-5r3kf9wa	13	10	Covid-19	covid-19	NN
cord-322798-5r3kf9wa	13	11	taskforce	taskforce	NN
cord-322798-5r3kf9wa	13	12	,	,	,
cord-322798-5r3kf9wa	13	13	which	which	WDT
cord-322798-5r3kf9wa	13	14	published	publish	VBD
cord-322798-5r3kf9wa	13	15	interim	interim	JJ
cord-322798-5r3kf9wa	13	16	guidance	guidance	NN
cord-322798-5r3kf9wa	13	17	within	within	IN
cord-322798-5r3kf9wa	13	18	five	five	CD
cord-322798-5r3kf9wa	13	19	days	day	NNS
cord-322798-5r3kf9wa	13	20	of	of	IN
cord-322798-5r3kf9wa	13	21	establishment	establishment	NN
cord-322798-5r3kf9wa	13	22	.	.	.
cord-322798-5r3kf9wa	14	1	Although	although	IN
cord-322798-5r3kf9wa	14	2	this	this	DT
cord-322798-5r3kf9wa	14	3	advice	advice	NN
cord-322798-5r3kf9wa	14	4	is	be	VBZ
cord-322798-5r3kf9wa	14	5	essential	essential	JJ
cord-322798-5r3kf9wa	14	6	,	,	,
cord-322798-5r3kf9wa	14	7	it	-PRON-	PRP
cord-322798-5r3kf9wa	14	8	is	be	VBZ
cord-322798-5r3kf9wa	14	9	by	by	IN
cord-322798-5r3kf9wa	14	10	necessity	necessity	NN
cord-322798-5r3kf9wa	14	11	made	make	VBN
cord-322798-5r3kf9wa	14	12	on	on	IN
cord-322798-5r3kf9wa	14	13	limited	limited	JJ
cord-322798-5r3kf9wa	14	14	and	and	CC
cord-322798-5r3kf9wa	14	15	rapidly	rapidly	RB
cord-322798-5r3kf9wa	14	16	evolving	evolve	VBG
cord-322798-5r3kf9wa	14	17	evidence	evidence	NN
cord-322798-5r3kf9wa	14	18	,	,	,
cord-322798-5r3kf9wa	14	19	and	and	CC
cord-322798-5r3kf9wa	14	20	must	must	MD
cord-322798-5r3kf9wa	14	21	be	be	VB
cord-322798-5r3kf9wa	14	22	tailored	tailor	VBN
cord-322798-5r3kf9wa	14	23	to	to	IN
cord-322798-5r3kf9wa	14	24	individual	individual	JJ
cord-322798-5r3kf9wa	14	25	patients	patient	NNS
cord-322798-5r3kf9wa	14	26	.	.	.
cord-322798-5r3kf9wa	15	1	Issues	issue	NNS
cord-322798-5r3kf9wa	15	2	include	include	VBP
cord-322798-5r3kf9wa	15	3	how	how	WRB
cord-322798-5r3kf9wa	15	4	to	to	TO
cord-322798-5r3kf9wa	15	5	grade	grade	VB
cord-322798-5r3kf9wa	15	6	evidence	evidence	NN
cord-322798-5r3kf9wa	15	7	from	from	IN
cord-322798-5r3kf9wa	15	8	gray	gray	JJ
cord-322798-5r3kf9wa	15	9	literature	literature	NN
cord-322798-5r3kf9wa	15	10	,	,	,
cord-322798-5r3kf9wa	15	11	risks	risk	NNS
cord-322798-5r3kf9wa	15	12	and	and	CC
cord-322798-5r3kf9wa	15	13	benefits	benefit	NNS
cord-322798-5r3kf9wa	15	14	of	of	IN
cord-322798-5r3kf9wa	15	15	use	use	NN
cord-322798-5r3kf9wa	15	16	of	of	IN
cord-322798-5r3kf9wa	15	17	anecdotal	anecdotal	JJ
cord-322798-5r3kf9wa	15	18	experiences	experience	NNS
cord-322798-5r3kf9wa	15	19	and	and	CC
cord-322798-5r3kf9wa	15	20	indirect	indirect	JJ
cord-322798-5r3kf9wa	15	21	evidence	evidence	NN
cord-322798-5r3kf9wa	15	22	,	,	,
cord-322798-5r3kf9wa	15	23	and	and	CC
cord-322798-5r3kf9wa	15	24	harmonizing	harmonize	VBG
cord-322798-5r3kf9wa	15	25	guidance	guidance	NN
cord-322798-5r3kf9wa	15	26	simultaneously	simultaneously	RB
cord-322798-5r3kf9wa	15	27	produced	produce	VBN
cord-322798-5r3kf9wa	15	28	by	by	IN
cord-322798-5r3kf9wa	15	29	other	other	JJ
cord-322798-5r3kf9wa	15	30	organizations	organization	NNS
cord-322798-5r3kf9wa	15	31	.	.	.
cord-322798-5r3kf9wa	16	1	The	the	DT
cord-322798-5r3kf9wa	16	2	harms	harm	NNS
cord-322798-5r3kf9wa	16	3	of	of	IN
cord-322798-5r3kf9wa	16	4	potentially	potentially	RB
cord-322798-5r3kf9wa	16	5	issuing	issue	VBG
cord-322798-5r3kf9wa	16	6	incorrect	incorrect	JJ
cord-322798-5r3kf9wa	16	7	guidance	guidance	NN
cord-322798-5r3kf9wa	16	8	must	must	MD
cord-322798-5r3kf9wa	16	9	be	be	VB
cord-322798-5r3kf9wa	16	10	balanced	balance	VBN
cord-322798-5r3kf9wa	16	11	with	with	IN
cord-322798-5r3kf9wa	16	12	the	the	DT
cord-322798-5r3kf9wa	16	13	ethical	ethical	JJ
cord-322798-5r3kf9wa	16	14	risks	risk	NNS
cord-322798-5r3kf9wa	16	15	of	of	IN
cord-322798-5r3kf9wa	16	16	issuing	issue	VBG
cord-322798-5r3kf9wa	16	17	no	no	DT
cord-322798-5r3kf9wa	16	18	guidance	guidance	NN
cord-322798-5r3kf9wa	16	19	at	at	RB
cord-322798-5r3kf9wa	16	20	all	all	RB
cord-322798-5r3kf9wa	16	21	.	.	.
cord-322798-5r3kf9wa	17	1	2	2	LS
cord-322798-5r3kf9wa	18	1	One	one	CD
cord-322798-5r3kf9wa	18	2	example	example	NN
cord-322798-5r3kf9wa	18	3	of	of	IN
cord-322798-5r3kf9wa	18	4	this	this	DT
cord-322798-5r3kf9wa	18	5	challenge	challenge	NN
cord-322798-5r3kf9wa	18	6	is	be	VBZ
cord-322798-5r3kf9wa	18	7	managing	manage	VBG
cord-322798-5r3kf9wa	18	8	patients	patient	NNS
cord-322798-5r3kf9wa	18	9	on	on	IN
cord-322798-5r3kf9wa	18	10	immunosuppressives	immunosuppressive	NNS
cord-322798-5r3kf9wa	18	11	during	during	IN
cord-322798-5r3kf9wa	18	12	Covid-19	Covid-19	NNP
cord-322798-5r3kf9wa	18	13	.	.	.
cord-322798-5r3kf9wa	19	1	A	a	DT
cord-322798-5r3kf9wa	19	2	recent	recent	JJ
cord-322798-5r3kf9wa	19	3	JAAD	JAAD	NNP
cord-322798-5r3kf9wa	19	4	study	study	NN
cord-322798-5r3kf9wa	19	5	examined	examine	VBD
cord-322798-5r3kf9wa	19	6	the	the	DT
cord-322798-5r3kf9wa	19	7	occurrence	occurrence	NN
cord-322798-5r3kf9wa	19	8	of	of	IN
cord-322798-5r3kf9wa	19	9	upper	upper	JJ
cord-322798-5r3kf9wa	19	10	respiratory	respiratory	JJ
cord-322798-5r3kf9wa	19	11	infection	infection	NN
cord-322798-5r3kf9wa	19	12	(	(	-LRB-
cord-322798-5r3kf9wa	19	13	URI	URI	NNP
cord-322798-5r3kf9wa	19	14	)	)	-RRB-
cord-322798-5r3kf9wa	19	15	for	for	IN
cord-322798-5r3kf9wa	19	16	patients	patient	NNS
cord-322798-5r3kf9wa	19	17	treated	treat	VBN
cord-322798-5r3kf9wa	19	18	with	with	IN
cord-322798-5r3kf9wa	19	19	various	various	JJ
cord-322798-5r3kf9wa	19	20	classes	class	NNS
cord-322798-5r3kf9wa	19	21	of	of	IN
cord-322798-5r3kf9wa	19	22	biologic	biologic	JJ
cord-322798-5r3kf9wa	19	23	therapies	therapy	NNS
cord-322798-5r3kf9wa	19	24	for	for	IN
cord-322798-5r3kf9wa	19	25	psoriasis	psoriasis	NN
cord-322798-5r3kf9wa	19	26	,	,	,
cord-322798-5r3kf9wa	19	27	as	as	IN
cord-322798-5r3kf9wa	19	28	a	a	DT
cord-322798-5r3kf9wa	19	29	proxy	proxy	NN
cord-322798-5r3kf9wa	19	30	for	for	IN
cord-322798-5r3kf9wa	19	31	risk	risk	NN
cord-322798-5r3kf9wa	19	32	of	of	IN
cord-322798-5r3kf9wa	19	33	Covid-19	covid-19	JJ
cord-322798-5r3kf9wa	19	34	infection	infection	NN
cord-322798-5r3kf9wa	19	35	while	while	IN
cord-322798-5r3kf9wa	19	36	on	on	IN
cord-322798-5r3kf9wa	19	37	a	a	DT
cord-322798-5r3kf9wa	19	38	biologic	biologic	NN
cord-322798-5r3kf9wa	19	39	.	.	.
cord-322798-5r3kf9wa	20	1	3	3	LS
cord-322798-5r3kf9wa	21	1	While	while	IN
cord-322798-5r3kf9wa	21	2	we	-PRON-	PRP
cord-322798-5r3kf9wa	21	3	commend	commend	VBP
cord-322798-5r3kf9wa	21	4	the	the	DT
cord-322798-5r3kf9wa	21	5	authors	author	NNS
cord-322798-5r3kf9wa	21	6	for	for	IN
cord-322798-5r3kf9wa	21	7	compiling	compile	VBG
cord-322798-5r3kf9wa	21	8	this	this	DT
cord-322798-5r3kf9wa	21	9	data	datum	NNS
cord-322798-5r3kf9wa	21	10	,	,	,
cord-322798-5r3kf9wa	21	11	there	there	EX
cord-322798-5r3kf9wa	21	12	are	be	VBP
cord-322798-5r3kf9wa	21	13	several	several	JJ
cord-322798-5r3kf9wa	21	14	issues	issue	NNS
cord-322798-5r3kf9wa	21	15	with	with	IN
cord-322798-5r3kf9wa	21	16	indirect	indirect	JJ
cord-322798-5r3kf9wa	21	17	evidence	evidence	NN
cord-322798-5r3kf9wa	21	18	:	:	:
cord-322798-5r3kf9wa	21	19	i	i	NN
cord-322798-5r3kf9wa	21	20	)	)	-RRB-
cord-322798-5r3kf9wa	22	1	these	these	DT
cord-322798-5r3kf9wa	22	2	trials	trial	NNS
cord-322798-5r3kf9wa	22	3	compared	compare	VBD
cord-322798-5r3kf9wa	22	4	biologics	biologic	NNS
cord-322798-5r3kf9wa	22	5	to	to	IN
cord-322798-5r3kf9wa	22	6	placebo	placebo	NN
cord-322798-5r3kf9wa	22	7	,	,	,
cord-322798-5r3kf9wa	22	8	ii	ii	LS
cord-322798-5r3kf9wa	22	9	)	)	-RRB-
cord-322798-5r3kf9wa	23	1	they	-PRON-	PRP
cord-322798-5r3kf9wa	23	2	were	be	VBD
cord-322798-5r3kf9wa	23	3	not	not	RB
cord-322798-5r3kf9wa	23	4	powered	power	VBN
cord-322798-5r3kf9wa	23	5	for	for	IN
cord-322798-5r3kf9wa	23	6	the	the	DT
cord-322798-5r3kf9wa	23	7	outcome	outcome	NN
cord-322798-5r3kf9wa	23	8	of	of	IN
cord-322798-5r3kf9wa	23	9	URI	URI	NNP
cord-322798-5r3kf9wa	23	10	,	,	,
cord-322798-5r3kf9wa	23	11	and	and	CC
cord-322798-5r3kf9wa	23	12	iii	iii	LS
cord-322798-5r3kf9wa	23	13	)	)	-RRB-
cord-322798-5r3kf9wa	24	1	the	the	DT
cord-322798-5r3kf9wa	24	2	similarity	similarity	NN
cord-322798-5r3kf9wa	24	3	of	of	IN
cord-322798-5r3kf9wa	24	4	Covid-19	covid-19	NN
cord-322798-5r3kf9wa	24	5	to	to	IN
cord-322798-5r3kf9wa	24	6	URI	URI	NNP
cord-322798-5r3kf9wa	24	7	is	be	VBZ
cord-322798-5r3kf9wa	24	8	unknown	unknown	JJ
cord-322798-5r3kf9wa	24	9	.	.	.
cord-322798-5r3kf9wa	25	1	Due	due	IN
cord-322798-5r3kf9wa	25	2	in	in	IN
cord-322798-5r3kf9wa	25	3	part	part	NN
cord-322798-5r3kf9wa	25	4	to	to	IN
cord-322798-5r3kf9wa	25	5	these	these	DT
cord-322798-5r3kf9wa	25	6	concerns	concern	NNS
cord-322798-5r3kf9wa	25	7	,	,	,
cord-322798-5r3kf9wa	25	8	the	the	DT
cord-322798-5r3kf9wa	25	9	AAD	AAD	NNP
cord-322798-5r3kf9wa	25	10	Covid-19	Covid-19	NNP
cord-322798-5r3kf9wa	25	11	taskforce	taskforce	NN
cord-322798-5r3kf9wa	25	12	published	publish	VBD
cord-322798-5r3kf9wa	25	13	interim	interim	JJ
cord-322798-5r3kf9wa	25	14	guidance	guidance	NN
cord-322798-5r3kf9wa	25	15	that	that	WDT
cord-322798-5r3kf9wa	25	16	did	do	VBD
cord-322798-5r3kf9wa	25	17	not	not	RB
cord-322798-5r3kf9wa	25	18	distinguish	distinguish	VB
cord-322798-5r3kf9wa	25	19	among	among	IN
cord-322798-5r3kf9wa	25	20	biologic	biologic	JJ
cord-322798-5r3kf9wa	25	21	classes	class	NNS
cord-322798-5r3kf9wa	25	22	.	.	.
cord-322798-5r3kf9wa	26	1	Dermatology	dermatology	NN
cord-322798-5r3kf9wa	26	2	societies	society	NNS
cord-322798-5r3kf9wa	26	3	are	be	VBP
cord-322798-5r3kf9wa	26	4	not	not	RB
cord-322798-5r3kf9wa	26	5	struggling	struggle	VBG
cord-322798-5r3kf9wa	26	6	alone	alone	RB
cord-322798-5r3kf9wa	26	7	with	with	IN
cord-322798-5r3kf9wa	26	8	creating	create	VBG
cord-322798-5r3kf9wa	26	9	interim	interim	JJ
cord-322798-5r3kf9wa	26	10	guidelines	guideline	NNS
cord-322798-5r3kf9wa	26	11	.	.	.
cord-322798-5r3kf9wa	27	1	In	in	IN
cord-322798-5r3kf9wa	27	2	cardiology	cardiology	NN
cord-322798-5r3kf9wa	27	3	,	,	,
cord-322798-5r3kf9wa	27	4	there	there	EX
cord-322798-5r3kf9wa	27	5	has	have	VBZ
cord-322798-5r3kf9wa	27	6	been	be	VBN
cord-322798-5r3kf9wa	27	7	concern	concern	NN
cord-322798-5r3kf9wa	27	8	over	over	IN
cord-322798-5r3kf9wa	27	9	the	the	DT
cord-322798-5r3kf9wa	27	10	use	use	NN
cord-322798-5r3kf9wa	27	11	of	of	IN
cord-322798-5r3kf9wa	27	12	angiotensin	angiotensin	NN
cord-322798-5r3kf9wa	27	13	converting	convert	VBG
cord-322798-5r3kf9wa	27	14	enzyme	enzyme	NN
cord-322798-5r3kf9wa	27	15	(	(	-LRB-
cord-322798-5r3kf9wa	27	16	ACE)-inhibitors	ACE)-inhibitors	NNP
cord-322798-5r3kf9wa	27	17	due	due	JJ
cord-322798-5r3kf9wa	27	18	to	to	IN
cord-322798-5r3kf9wa	27	19	an	an	DT
cord-322798-5r3kf9wa	27	20	observational	observational	JJ
cord-322798-5r3kf9wa	27	21	study	study	NN
cord-322798-5r3kf9wa	27	22	that	that	IN
cord-322798-5r3kf9wa	27	23	many	many	JJ
cord-322798-5r3kf9wa	27	24	patients	patient	NNS
cord-322798-5r3kf9wa	27	25	with	with	IN
cord-322798-5r3kf9wa	27	26	hypertension	hypertension	NN
cord-322798-5r3kf9wa	27	27	admitted	admit	VBN
cord-322798-5r3kf9wa	27	28	for	for	IN
cord-322798-5r3kf9wa	27	29	Covid-19	Covid-19	NNP
cord-322798-5r3kf9wa	27	30	were	be	VBD
cord-322798-5r3kf9wa	27	31	on	on	IN
cord-322798-5r3kf9wa	27	32	ACE	ace	NN
cord-322798-5r3kf9wa	27	33	-	-	HYPH
cord-322798-5r3kf9wa	27	34	inhibitors	inhibitor	NNS
cord-322798-5r3kf9wa	27	35	.	.	.
cord-322798-5r3kf9wa	28	1	4	4	LS
cord-322798-5r3kf9wa	29	1	In	in	IN
cord-322798-5r3kf9wa	29	2	the	the	DT
cord-322798-5r3kf9wa	29	3	face	face	NN
cord-322798-5r3kf9wa	29	4	of	of	IN
cord-322798-5r3kf9wa	29	5	uncertainty	uncertainty	NN
cord-322798-5r3kf9wa	29	6	,	,	,
cord-322798-5r3kf9wa	29	7	societies	society	NNS
cord-322798-5r3kf9wa	29	8	including	include	VBG
cord-322798-5r3kf9wa	29	9	the	the	DT
cord-322798-5r3kf9wa	29	10	American	American	NNP
cord-322798-5r3kf9wa	29	11	College	College	NNP
cord-322798-5r3kf9wa	29	12	of	of	IN
cord-322798-5r3kf9wa	29	13	Cardiology	Cardiology	NNP
cord-322798-5r3kf9wa	29	14	took	take	VBD
cord-322798-5r3kf9wa	29	15	a	a	DT
cord-322798-5r3kf9wa	29	16	stance	stance	NN
cord-322798-5r3kf9wa	29	17	to	to	TO
cord-322798-5r3kf9wa	29	18	keep	keep	VB
cord-322798-5r3kf9wa	29	19	patients	patient	NNS
cord-322798-5r3kf9wa	29	20	on	on	IN
cord-322798-5r3kf9wa	29	21	ACE	ace	NN
cord-322798-5r3kf9wa	29	22	-	-	HYPH
cord-322798-5r3kf9wa	29	23	inhibitors	inhibitor	NNS
cord-322798-5r3kf9wa	29	24	while	while	IN
cord-322798-5r3kf9wa	29	25	they	-PRON-	PRP
cord-322798-5r3kf9wa	29	26	await	await	VBP
cord-322798-5r3kf9wa	29	27	more	more	JJR
cord-322798-5r3kf9wa	29	28	evidence	evidence	NN
cord-322798-5r3kf9wa	29	29	.	.	.
cord-322798-5r3kf9wa	30	1	5	5	LS
cord-322798-5r3kf9wa	31	1	When	when	WRB
cord-322798-5r3kf9wa	31	2	guidelines	guideline	NNS
cord-322798-5r3kf9wa	31	3	can	can	MD
cord-322798-5r3kf9wa	31	4	no	no	RB
cord-322798-5r3kf9wa	31	5	longer	longer	RB
cord-322798-5r3kf9wa	31	6	be	be	VB
cord-322798-5r3kf9wa	31	7	based	base	VBN
cord-322798-5r3kf9wa	31	8	on	on	IN
cord-322798-5r3kf9wa	31	9	the	the	DT
cord-322798-5r3kf9wa	31	10	highest	high	JJS
cord-322798-5r3kf9wa	31	11	level	level	NN
cord-322798-5r3kf9wa	31	12	of	of	IN
cord-322798-5r3kf9wa	31	13	evidence	evidence	NN
cord-322798-5r3kf9wa	31	14	,	,	,
cord-322798-5r3kf9wa	31	15	then	then	RB
cord-322798-5r3kf9wa	31	16	indirect	indirect	JJ
cord-322798-5r3kf9wa	31	17	studies	study	NNS
cord-322798-5r3kf9wa	31	18	,	,	,
cord-322798-5r3kf9wa	31	19	gray	gray	JJ
cord-322798-5r3kf9wa	31	20	literature	literature	NN
cord-322798-5r3kf9wa	31	21	,	,	,
cord-322798-5r3kf9wa	31	22	case	case	NN
cord-322798-5r3kf9wa	31	23	-	-	HYPH
cord-322798-5r3kf9wa	31	24	reports	report	NNS
cord-322798-5r3kf9wa	31	25	and	and	CC
cord-322798-5r3kf9wa	31	26	expert	expert	NN
cord-322798-5r3kf9wa	31	27	consensus	consensus	NN
cord-322798-5r3kf9wa	31	28	may	may	MD
cord-322798-5r3kf9wa	31	29	be	be	VB
cord-322798-5r3kf9wa	31	30	the	the	DT
cord-322798-5r3kf9wa	31	31	only	only	JJ
cord-322798-5r3kf9wa	31	32	tools	tool	NNS
cord-322798-5r3kf9wa	31	33	left	leave	VBN
cord-322798-5r3kf9wa	31	34	in	in	IN
cord-322798-5r3kf9wa	31	35	our	-PRON-	PRP$
cord-322798-5r3kf9wa	31	36	arsenal	arsenal	NN
cord-322798-5r3kf9wa	31	37	.	.	.
cord-322798-5r3kf9wa	32	1	We	-PRON-	PRP
cord-322798-5r3kf9wa	32	2	need	need	VBP
cord-322798-5r3kf9wa	32	3	3	3	CD
cord-322798-5r3kf9wa	32	4	guidance	guidance	NN
cord-322798-5r3kf9wa	32	5	not	not	RB
cord-322798-5r3kf9wa	32	6	just	just	RB
cord-322798-5r3kf9wa	32	7	on	on	IN
cord-322798-5r3kf9wa	32	8	biologics	biologic	NNS
cord-322798-5r3kf9wa	32	9	,	,	,
cord-322798-5r3kf9wa	32	10	but	but	CC
cord-322798-5r3kf9wa	32	11	many	many	JJ
cord-322798-5r3kf9wa	32	12	topics	topic	NNS
cord-322798-5r3kf9wa	32	13	,	,	,
cord-322798-5r3kf9wa	32	14	including	include	VBG
cord-322798-5r3kf9wa	32	15	scaling	scale	VBG
cord-322798-5r3kf9wa	32	16	up	up	RP
cord-322798-5r3kf9wa	32	17	teledermatology	teledermatology	NNP
cord-322798-5r3kf9wa	32	18	programs	program	NNS
cord-322798-5r3kf9wa	32	19	and	and	CC
cord-322798-5r3kf9wa	32	20	managing	manage	VBG
cord-322798-5r3kf9wa	32	21	patients	patient	NNS
cord-322798-5r3kf9wa	32	22	with	with	IN
cord-322798-5r3kf9wa	32	23	invasive	invasive	JJ
cord-322798-5r3kf9wa	32	24	skin	skin	NN
cord-322798-5r3kf9wa	32	25	cancers	cancer	NNS
cord-322798-5r3kf9wa	32	26	.	.	.
cord-322798-5r3kf9wa	33	1	These	these	DT
cord-322798-5r3kf9wa	33	2	changes	change	NNS
cord-322798-5r3kf9wa	33	3	to	to	IN
cord-322798-5r3kf9wa	33	4	dermatology	dermatology	NN
cord-322798-5r3kf9wa	33	5	guidelines	guideline	NNS
cord-322798-5r3kf9wa	33	6	do	do	VBP
cord-322798-5r3kf9wa	33	7	not	not	RB
cord-322798-5r3kf9wa	33	8	exist	exist	VB
cord-322798-5r3kf9wa	33	9	in	in	IN
cord-322798-5r3kf9wa	33	10	a	a	DT
cord-322798-5r3kf9wa	33	11	vacuum	vacuum	NN
cord-322798-5r3kf9wa	33	12	;	;	:
cord-322798-5r3kf9wa	33	13	important	important	JJ
cord-322798-5r3kf9wa	33	14	ethical	ethical	JJ
cord-322798-5r3kf9wa	33	15	implications	implication	NNS
cord-322798-5r3kf9wa	33	16	include	include	VBP
cord-322798-5r3kf9wa	33	17	patient	patient	JJ
cord-322798-5r3kf9wa	33	18	outcomes	outcome	NNS
cord-322798-5r3kf9wa	33	19	such	such	JJ
cord-322798-5r3kf9wa	33	20	as	as	IN
cord-322798-5r3kf9wa	33	21	missed	miss	VBN
cord-322798-5r3kf9wa	33	22	melanomas	melanoma	NNS
cord-322798-5r3kf9wa	33	23	and	and	CC
cord-322798-5r3kf9wa	33	24	the	the	DT
cord-322798-5r3kf9wa	33	25	loss	loss	NN
cord-322798-5r3kf9wa	33	26	of	of	IN
cord-322798-5r3kf9wa	33	27	employment	employment	NN
cord-322798-5r3kf9wa	33	28	for	for	IN
cord-322798-5r3kf9wa	33	29	practice	practice	NN
cord-322798-5r3kf9wa	33	30	staff	staff	NN
cord-322798-5r3kf9wa	33	31	.	.	.
cord-322798-5r3kf9wa	34	1	With	with	IN
cord-322798-5r3kf9wa	34	2	so	so	RB
cord-322798-5r3kf9wa	34	3	much	much	JJ
cord-322798-5r3kf9wa	34	4	uncertainty	uncertainty	NN
cord-322798-5r3kf9wa	34	5	in	in	IN
cord-322798-5r3kf9wa	34	6	our	-PRON-	PRP$
cord-322798-5r3kf9wa	34	7	medical	medical	JJ
cord-322798-5r3kf9wa	34	8	practice	practice	NN
cord-322798-5r3kf9wa	34	9	,	,	,
cord-322798-5r3kf9wa	34	10	guidance	guidance	NN
cord-322798-5r3kf9wa	34	11	is	be	VBZ
cord-322798-5r3kf9wa	34	12	needed	need	VBN
cord-322798-5r3kf9wa	34	13	now	now	RB
cord-322798-5r3kf9wa	34	14	more	more	RBR
cord-322798-5r3kf9wa	34	15	than	than	IN
cord-322798-5r3kf9wa	34	16	ever	ever	RB
cord-322798-5r3kf9wa	34	17	.	.	.
cord-322798-5r3kf9wa	35	1	We	-PRON-	PRP
cord-322798-5r3kf9wa	35	2	should	should	MD
cord-322798-5r3kf9wa	35	3	acknowledge	acknowledge	VB
cord-322798-5r3kf9wa	35	4	the	the	DT
cord-322798-5r3kf9wa	35	5	shift	shift	NN
cord-322798-5r3kf9wa	35	6	from	from	IN
cord-322798-5r3kf9wa	35	7	evidence	evidence	NN
cord-322798-5r3kf9wa	35	8	based	base	VBN
cord-322798-5r3kf9wa	35	9	medicine	medicine	NN
cord-322798-5r3kf9wa	35	10	to	to	IN
cord-322798-5r3kf9wa	35	11	reliance	reliance	NN
cord-322798-5r3kf9wa	35	12	on	on	IN
cord-322798-5r3kf9wa	35	13	expert	expert	JJ
cord-322798-5r3kf9wa	35	14	guidance	guidance	NN
cord-322798-5r3kf9wa	35	15	,	,	,
cord-322798-5r3kf9wa	35	16	and	and	CC
cord-322798-5r3kf9wa	35	17	appreciate	appreciate	VBP
cord-322798-5r3kf9wa	35	18	the	the	DT
cord-322798-5r3kf9wa	35	19	potential	potential	NN
cord-322798-5r3kf9wa	35	20	for	for	IN
cord-322798-5r3kf9wa	35	21	guideline	guideline	NN
cord-322798-5r3kf9wa	35	22	reversal	reversal	NN
cord-322798-5r3kf9wa	35	23	.	.	.
cord-322798-5r3kf9wa	36	1	But	but	CC
cord-322798-5r3kf9wa	36	2	in	in	IN
cord-322798-5r3kf9wa	36	3	a	a	DT
cord-322798-5r3kf9wa	36	4	time	time	NN
cord-322798-5r3kf9wa	36	5	of	of	IN
cord-322798-5r3kf9wa	36	6	rapidly	rapidly	RB
cord-322798-5r3kf9wa	36	7	changing	change	VBG
cord-322798-5r3kf9wa	36	8	evidence	evidence	NN
cord-322798-5r3kf9wa	36	9	,	,	,
cord-322798-5r3kf9wa	36	10	we	-PRON-	PRP
cord-322798-5r3kf9wa	36	11	must	must	MD
cord-322798-5r3kf9wa	36	12	be	be	VB
cord-322798-5r3kf9wa	36	13	willing	willing	JJ
cord-322798-5r3kf9wa	36	14	to	to	TO
cord-322798-5r3kf9wa	36	15	take	take	VB
cord-322798-5r3kf9wa	36	16	on	on	RP
cord-322798-5r3kf9wa	36	17	these	these	DT
cord-322798-5r3kf9wa	36	18	risks	risk	NNS
cord-322798-5r3kf9wa	36	19	to	to	TO
cord-322798-5r3kf9wa	36	20	guide	guide	VB
cord-322798-5r3kf9wa	36	21	with	with	IN
cord-322798-5r3kf9wa	36	22	the	the	DT
cord-322798-5r3kf9wa	36	23	goal	goal	NN
cord-322798-5r3kf9wa	36	24	of	of	IN
cord-322798-5r3kf9wa	36	25	maintaining	maintain	VBG
cord-322798-5r3kf9wa	36	26	the	the	DT
cord-322798-5r3kf9wa	36	27	highest	high	JJS
cord-322798-5r3kf9wa	36	28	standard	standard	NN
cord-322798-5r3kf9wa	36	29	of	of	IN
cord-322798-5r3kf9wa	36	30	patient	patient	JJ
cord-322798-5r3kf9wa	36	31	care	care	NN
cord-322798-5r3kf9wa	36	32	.	.	.
cord-322798-5r3kf9wa	37	1	Modernizing	modernize	VBG
cord-322798-5r3kf9wa	37	2	clinical	clinical	JJ
cord-322798-5r3kf9wa	37	3	practice	practice	NN
cord-322798-5r3kf9wa	37	4	guidelines	guideline	NNS
cord-322798-5r3kf9wa	37	5	for	for	IN
cord-322798-5r3kf9wa	37	6	the	the	DT
cord-322798-5r3kf9wa	37	7	American	American	NNP
cord-322798-5r3kf9wa	37	8	Academy	Academy	NNP
cord-322798-5r3kf9wa	37	9	of	of	IN
cord-322798-5r3kf9wa	37	10	Dermatology	Dermatology	NNP
cord-322798-5r3kf9wa	37	11	Fair	Fair	NNP
cord-322798-5r3kf9wa	37	12	Allocation	Allocation	NNP
cord-322798-5r3kf9wa	37	13	of	of	IN
cord-322798-5r3kf9wa	37	14	Scarce	Scarce	NNP
cord-322798-5r3kf9wa	37	15	Medical	Medical	NNP
cord-322798-5r3kf9wa	37	16	Resources	Resources	NNPS
cord-322798-5r3kf9wa	37	17	in	in	IN
cord-322798-5r3kf9wa	37	18	the	the	DT
cord-322798-5r3kf9wa	37	19	Time	Time	NNP
cord-322798-5r3kf9wa	37	20	of	of	IN
cord-322798-5r3kf9wa	37	21	Covid-19	Covid-19	NNP
cord-322798-5r3kf9wa	37	22	Should	Should	NNP
cord-322798-5r3kf9wa	37	23	biologics	biologic	NNS
cord-322798-5r3kf9wa	37	24	for	for	IN
cord-322798-5r3kf9wa	37	25	psoriasis	psoriasis	NN
cord-322798-5r3kf9wa	37	26	be	be	VB
cord-322798-5r3kf9wa	37	27	interrupted	interrupt	VBN
cord-322798-5r3kf9wa	37	28	in	in	IN
cord-322798-5r3kf9wa	37	29	the	the	DT
cord-322798-5r3kf9wa	37	30	era	era	NN
cord-322798-5r3kf9wa	37	31	of	of	IN
cord-322798-5r3kf9wa	37	32	COVID-19	COVID-19	NNP
cord-322798-5r3kf9wa	37	33	?	?	.
cord-322798-5r3kf9wa	38	1	Are	be	VBP
cord-322798-5r3kf9wa	38	2	patients	patient	NNS
cord-322798-5r3kf9wa	38	3	with	with	IN
cord-322798-5r3kf9wa	38	4	hypertension	hypertension	NN
cord-322798-5r3kf9wa	38	5	and	and	CC
cord-322798-5r3kf9wa	38	6	diabetes	diabetes	NN
cord-322798-5r3kf9wa	38	7	mellitus	mellitus	NN
cord-322798-5r3kf9wa	38	8	at	at	IN
cord-322798-5r3kf9wa	38	9	increased	increase	VBN
cord-322798-5r3kf9wa	38	10	risk	risk	NN
cord-322798-5r3kf9wa	38	11	for	for	IN
cord-322798-5r3kf9wa	38	12	COVID-19	covid-19	JJ
cord-322798-5r3kf9wa	38	13	infection	infection	NN
cord-322798-5r3kf9wa	38	14	?	?	.
cord-322798-5r3kf9wa	39	1	Patients	patient	NNS
cord-322798-5r3kf9wa	39	2	taking	take	VBG
cord-322798-5r3kf9wa	39	3	ACE	ACE	NNP
cord-322798-5r3kf9wa	39	4	-	-	HYPH
cord-322798-5r3kf9wa	39	5	i	i	PRP
cord-322798-5r3kf9wa	39	6	and	and	CC
cord-322798-5r3kf9wa	39	7	ARBs	ARBs	NNPS
cord-322798-5r3kf9wa	39	8	who	who	WP
cord-322798-5r3kf9wa	39	9	contract	contract	VBP
cord-322798-5r3kf9wa	39	10	COVID-19	COVID-19	NNP
cord-322798-5r3kf9wa	39	11	should	should	MD
cord-322798-5r3kf9wa	39	12	continue	continue	VB
cord-322798-5r3kf9wa	39	13	treatment	treatment	NN
cord-322798-5r3kf9wa	39	14	,	,	,
cord-322798-5r3kf9wa	39	15	unless	unless	IN
cord-322798-5r3kf9wa	39	16	otherwise	otherwise	RB
cord-322798-5r3kf9wa	39	17	advised	advise	VBN
cord-322798-5r3kf9wa	39	18	by	by	IN
cord-322798-5r3kf9wa	39	19	their	-PRON-	PRP$
cord-322798-5r3kf9wa	39	20	physician	physician	NN
cord-322798-5r3kf9wa	39	21	:	:	:
cord-322798-5r3kf9wa	40	1	Statement	statement	NN
cord-322798-5r3kf9wa	40	2	from	from	IN
cord-322798-5r3kf9wa	40	3	the	the	DT
cord-322798-5r3kf9wa	40	4	American	American	NNP
cord-322798-5r3kf9wa	40	5	Heart	Heart	NNP
cord-322798-5r3kf9wa	40	6	Association	Association	NNP
cord-322798-5r3kf9wa	40	7	,	,	,
cord-322798-5r3kf9wa	40	8	the	the	DT
cord-322798-5r3kf9wa	40	9	Heart	Heart	NNP
cord-322798-5r3kf9wa	40	10	Failure	Failure	NNP
cord-322798-5r3kf9wa	40	11	Society	Society	NNP
cord-322798-5r3kf9wa	40	12	of	of	IN
cord-322798-5r3kf9wa	40	13	America	America	NNP
cord-322798-5r3kf9wa	40	14	and	and	CC
cord-322798-5r3kf9wa	40	15	the	the	DT
cord-322798-5r3kf9wa	40	16	American	American	NNP
cord-322798-5r3kf9wa	40	17	College	College	NNP
cord-322798-5r3kf9wa	40	18	of	of	IN
cord-322798-5r3kf9wa	40	19	Cardiology	Cardiology	NNP
cord-322798-5r3kf9wa	41	1	The	the	DT
cord-322798-5r3kf9wa	41	2	authors	author	NNS
cord-322798-5r3kf9wa	41	3	would	would	MD
cord-322798-5r3kf9wa	41	4	like	like	VB
cord-322798-5r3kf9wa	41	5	to	to	TO
cord-322798-5r3kf9wa	41	6	acknowledge	acknowledge	VB
cord-322798-5r3kf9wa	41	7	Dr.	Dr.	NNP
cord-322798-5r3kf9wa	41	8	Benjamin	Benjamin	NNP
cord-322798-5r3kf9wa	41	9	Stoff	Stoff	NNP
cord-322798-5r3kf9wa	41	10	for	for	IN
cord-322798-5r3kf9wa	41	11	his	-PRON-	PRP$
cord-322798-5r3kf9wa	41	12	advice	advice	NN
cord-322798-5r3kf9wa	41	13	regarding	regard	VBG
cord-322798-5r3kf9wa	41	14	the	the	DT
cord-322798-5r3kf9wa	41	15	ethics	ethic	NNS
cord-322798-5r3kf9wa	41	16	of	of	IN
cord-322798-5r3kf9wa	41	17	clinical	clinical	JJ
cord-322798-5r3kf9wa	41	18	practice	practice	NN
cord-322798-5r3kf9wa	41	19	guideline	guideline	NN
cord-322798-5r3kf9wa	41	20	generation	generation	NN
cord-322798-5r3kf9wa	41	21	,	,	,
cord-322798-5r3kf9wa	41	22	as	as	RB
cord-322798-5r3kf9wa	41	23	well	well	RB
cord-322798-5r3kf9wa	41	24	as	as	IN
cord-322798-5r3kf9wa	41	25	Dr.	Dr.	NNP
cord-322798-5r3kf9wa	41	26	George	George	NNP
cord-322798-5r3kf9wa	41	27	Hruza	Hruza	NNP
cord-322798-5r3kf9wa	41	28	and	and	CC
cord-322798-5r3kf9wa	41	29	Dr.	Dr.	NNP
cord-322798-5r3kf9wa	41	30	Bruce	Bruce	NNP
cord-322798-5r3kf9wa	41	31	Thiers	Thiers	NNP
cord-322798-5r3kf9wa	41	32	for	for	IN
cord-322798-5r3kf9wa	41	33	their	-PRON-	PRP$
cord-322798-5r3kf9wa	41	34	comments	comment	NNS
cord-322798-5r3kf9wa	41	35	on	on	IN
cord-322798-5r3kf9wa	41	36	a	a	DT
cord-322798-5r3kf9wa	41	37	preliminary	preliminary	JJ
cord-322798-5r3kf9wa	41	38	draft	draft	NN
cord-322798-5r3kf9wa	41	39	of	of	IN
cord-322798-5r3kf9wa	41	40	this	this	DT
cord-322798-5r3kf9wa	41	41	manuscript	manuscript	NN
cord-322798-5r3kf9wa	41	42	.	.	.